Breast Cancer
Showing NaN - NaN of 215
Johns Hopkins Breast Cancer Program Longitudinal Repository
Recruiting
- Breast Cancer
- Benign Breast Disease
- Sample collection
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 20, 2022
Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)
Active, not recruiting
- Breast Cancer
- Palbociclib
- Standard Adjuvant Endocrine Therapy
-
Mobile, Alabama
- +437 more
Mar 21, 2022
Breast Cancer, Renal Cell Carcinoma Trial in United States (IPI-549 (eganelisib), Atezolizumab, nab-paclitaxel)
Active, not recruiting
- Breast Cancer
- Renal Cell Carcinoma
- IPI-549 (eganelisib)
- +3 more
-
Chandler, Arizona
- +23 more
Apr 1, 2022
Breast Cancer Trial in United States (Trastuzumab, Paclitaxel, Trastuzumab emtansine)
Triple-Negative Breast Tumors, Breast Tumor, Breast Cancer Trial in Worldwide (Trilaciclib, Gemcitabine, Carboplatin)
Terminated
- Triple-Negative Breast Neoplasms
- +3 more
- Trilaciclib
- +2 more
-
Tucson, Arizona
- +53 more
Feb 24, 2022
99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer
Recruiting
- Breast Cancer
- 99m Tc-TM
-
Baltimore, MarylandJohns Hopkins Bayview Hospital
Mar 7, 2022
Cardiotoxicity in Breast Cancer Patients Treated With Proton or
Enrolling by invitation
- Breast Cancer
- Cardiotoxicity
- Proton vs Photon Radiation
-
Birmingham, Alabama
- +5 more
Mar 4, 2022
Tamoxifen in Breast Cancer and in Women at High-Risk of Breast
Active, not recruiting
- Breast Cancer
- +3 more
- citalopram hydrobromide
- +10 more
-
Indianapolis, Indiana
- +3 more
Feb 18, 2022
Breast Cancer Trial in Washington, Baltimore (Stereotactic Body Radiation SBRT)
Recruiting
- Breast Cancer
- Stereotactic Body Radiation SBRT
-
Washington, District of Columbia
- +1 more
Jan 24, 2022
Breast Cancer Trial in Canada, Puerto Rico, United States (pegfilgrastim, AC regimen, cyclophosphamide)
Active, not recruiting
- Breast Cancer
- pegfilgrastim
- +4 more
-
Anniston, Alabama
- +541 more
Jan 19, 2022
Breast Cancer Trial in United States (The Gamma Pod, CT simulation)
Completed
- Breast Cancer
- The Gamma Pod
- CT simulation
-
Baltimore, Maryland
- +3 more
Jan 5, 2022
Postoperative Pain, Postoperative Nausea and Vomiting, Quality of Life Trial in Baltimore (Pre-pectoral Tissue Expander)
Completed
- Postoperative Pain
- +4 more
- Pre-pectoral Tissue Expander
-
Baltimore, MarylandThe Johns Hopkins University
Dec 15, 2021
Breast Cancer Trial in Baltimore (Tamoxifen Citrate, Letrozole, Exemestane)
Recruiting
- Breast Cancer
- Tamoxifen Citrate
- +4 more
-
Baltimore, MarylandJohns Hopkins Bayview Hospital
Nov 30, 2021
Breast Cancer Trial in United States (GammaPod Radiation)
Recruiting
- Breast Cancer
- GammaPod Radiation
-
Baltimore, Maryland
- +3 more
Nov 8, 2021
Breast Cancer, Breast Tumor, Breast Tumor Trial in United States (Proton Radiotherapy)
Recruiting
- Breast Cancer
- +3 more
- Proton Radiotherapy
-
San Diego, California
- +6 more
Oct 24, 2021
Breast Cancer, Breast Tumor, Breast Tumor Trial in United States (Proton Radiotherapy)
Active, not recruiting
- Breast Cancer
- +3 more
- Proton Radiotherapy
-
Warrenville, Illinois
- +4 more
Oct 24, 2021
Breast Cancer Trial in Canada, Ireland, United States (Letrozole, Placebo)
Metastasis, Breast Cancer Trial in Worldwide (NKTR-102, Eribulin, Ixabepilone)
Breast Cancer Trial in Baltimore (AZD9496 (Reference), AZD9496 Variant A, AZD9496 Variant B)
Completed
- Breast Cancer
- AZD9496 (Reference)
- +4 more
-
Baltimore, MarylandResearch Site
Aug 2, 2021
Cardiac MRI Biomarker Testing (GCC 1618)
Recruiting
- Breast Cancer
- +4 more
- Complete Cardiac Magnetic Resonance Imaging (MRI)
-
Baltimore, MarylandUmmc Msgccc
Aug 16, 2021